Xufeng Tao

3.4k total citations
66 papers, 2.7k citations indexed

About

Xufeng Tao is a scholar working on Molecular Biology, Surgery and Oncology. According to data from OpenAlex, Xufeng Tao has authored 66 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Molecular Biology, 21 papers in Surgery and 15 papers in Oncology. Recurrent topics in Xufeng Tao's work include Pancreatitis Pathology and Treatment (14 papers), Pancreatic and Hepatic Oncology Research (10 papers) and Liver Disease Diagnosis and Treatment (9 papers). Xufeng Tao is often cited by papers focused on Pancreatitis Pathology and Treatment (14 papers), Pancreatic and Hepatic Oncology Research (10 papers) and Liver Disease Diagnosis and Treatment (9 papers). Xufeng Tao collaborates with scholars based in China and United States. Xufeng Tao's co-authors include Lina Xu, Lianhong Yin, Jinyong Peng, Yan Qi, Youwei Xu, Xu Han, Xu Han, Lisha Zhao, Kexin Liu and Hong Xiang and has published in prestigious journals such as Free Radical Biology and Medicine, British Journal of Pharmacology and IEEE Access.

In The Last Decade

Xufeng Tao

64 papers receiving 2.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xufeng Tao China 29 1.3k 407 354 346 342 66 2.7k
Heqing Huang China 35 1.7k 1.3× 451 1.1× 193 0.5× 250 0.7× 315 0.9× 92 3.5k
Guang Liang China 40 2.3k 1.8× 621 1.5× 421 1.2× 529 1.5× 364 1.1× 129 4.7k
Lu Lu China 29 1.3k 1.0× 389 1.0× 250 0.7× 241 0.7× 228 0.7× 156 2.9k
Nehal M. Elsherbiny Egypt 36 1.2k 0.9× 304 0.7× 142 0.4× 257 0.7× 247 0.7× 114 3.2k
Xianglu Rong China 27 1.5k 1.2× 518 1.3× 336 0.9× 188 0.5× 232 0.7× 76 3.2k
Hua Zhou China 30 1.2k 0.9× 215 0.5× 235 0.7× 164 0.5× 215 0.6× 184 2.9k
Wu Luo China 26 1.3k 1.0× 283 0.7× 414 1.2× 244 0.7× 224 0.7× 92 2.5k
Samson Mathews Samuel Qatar 39 2.1k 1.7× 266 0.7× 240 0.7× 712 2.1× 320 0.9× 77 4.1k
Haitao Zhang China 36 1.4k 1.1× 246 0.6× 162 0.5× 477 1.4× 197 0.6× 139 3.2k

Countries citing papers authored by Xufeng Tao

Since Specialization
Citations

This map shows the geographic impact of Xufeng Tao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xufeng Tao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xufeng Tao more than expected).

Fields of papers citing papers by Xufeng Tao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xufeng Tao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xufeng Tao. The network helps show where Xufeng Tao may publish in the future.

Co-authorship network of co-authors of Xufeng Tao

This figure shows the co-authorship network connecting the top 25 collaborators of Xufeng Tao. A scholar is included among the top collaborators of Xufeng Tao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xufeng Tao. Xufeng Tao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zuo, Yufang, Shilei Yang, Xufeng Tao, et al.. (2025). Contribution and expression of renal drug transporters in renal cell carcinoma. Frontiers in Pharmacology. 15. 1466877–1466877. 3 indexed citations
2.
Guo, Fangyue, Xufeng Tao, Zhi‐Wen Zhai, et al.. (2025). The Peptide–Drug Conjugate M1pep–Tasquinimod Ameliorates Acute Pancreatitis via Selectively Clearing M1-like Macrophages. Biomaterials Research. 29. 250–250.
3.
4.
5.
Tang, Yu-Ting, et al.. (2023). ROS in hepatocellular carcinoma: What we know. Archives of Biochemistry and Biophysics. 744. 109699–109699. 20 indexed citations
6.
Zhai, Xiaohan, Xufeng Tao, Shilei Yang, et al.. (2023). Success stories of natural product-derived compounds from plants as multidrug resistance modulators in microorganisms. RSC Advances. 13(12). 7798–7817. 14 indexed citations
7.
Tao, Xufeng, Xiaohan Zhai, Zirui Zhao, et al.. (2023). Naringin against doxorubicin‐induced hepatotoxicity in mice through reducing oxidative stress, inflammation, and apoptosis via the up‐regulation of SIRT1. Environmental Toxicology. 38(5). 1153–1161. 22 indexed citations
8.
Xiang, Hong, et al.. (2022). Health Impacts of High BMI in China: Terrible Present and Future. International Journal of Environmental Research and Public Health. 19(23). 16173–16173. 8 indexed citations
9.
Xiang, Hong, et al.. (2022). Contemporary Chinese dietary pattern: Where are the hidden risks?. Frontiers in Nutrition. 9. 997773–997773. 11 indexed citations
10.
Wu, Yu, Qi Zhou, Fangyue Guo, et al.. (2021). S100 Proteins in Pancreatic Cancer: Current Knowledge and Future Perspectives. Frontiers in Oncology. 11. 711180–711180. 20 indexed citations
11.
Tao, Xufeng, Hong Xiang, Yue Pan, et al.. (2021). Pancreatitis initiated pancreatic ductal adenocarcinoma: Pathophysiology explaining clinical evidence. Pharmacological Research. 168. 105595–105595. 6 indexed citations
12.
Liu, Jianzhou, Xiaoyu Miao, Jing Huang, et al.. (2020). Obg-Like ATPase 1 Enhances Chemoresistance of Breast Cancer via Activation of TGF-β/Smad Axis Cascades. Frontiers in Pharmacology. 11. 666–666. 13 indexed citations
13.
Tao, Xufeng, Qing Chen, Ning Li, et al.. (2020). Serotonin-RhoA/ROCK axis promotes acinar-to-ductal metaplasia in caerulein-induced chronic pancreatitis. Biomedicine & Pharmacotherapy. 125. 109999–109999. 29 indexed citations
14.
Hu, Yu‐Peng, Mao Zhang, Lina Xu, et al.. (2018). Protective effect of dioscin against intestinal ischemia/reperfusion injury via adjusting miR-351-5p-mediated oxidative stress. Pharmacological Research. 137. 56–63. 55 indexed citations
15.
Zhang, Yimeng, Xufeng Tao, Lianhong Yin, et al.. (2017). Protective effects of dioscin against cisplatin‐induced nephrotoxicity via the microRNA‐34a/sirtuin 1 signalling pathway. British Journal of Pharmacology. 174(15). 2512–2527. 87 indexed citations
16.
Zhang, Yimeng, Youwei Xu, Yan Qi, et al.. (2017). Protective effects of dioscin against doxorubicin-induced nephrotoxicity via adjusting FXR-mediated oxidative stress and inflammation. Toxicology. 378. 53–64. 126 indexed citations
17.
Yao, Hong, Shasha Song, Yan Qi, et al.. (2017). Protective Effects of Dioscin against Lipopolysaccharide-Induced Acute Lung Injury through Inhibition of Oxidative Stress and Inflammation. Frontiers in Pharmacology. 8. 120–120. 69 indexed citations
18.
Yin, Lianhong, Yan Qi, Youwei Xu, et al.. (2017). Dioscin Inhibits HSC-T6 Cell Migration via Adjusting SDC-4 Expression: Insights from iTRAQ-Based Quantitative Proteomics. Frontiers in Pharmacology. 8. 1036–1036. 26 indexed citations
19.
Yao, Hong, Yujie Qiao, Xufeng Tao, et al.. (2016). Herbal medicines and nonalcoholic fatty liver disease. World Journal of Gastroenterology. 22(30). 6890–6890. 112 indexed citations
20.
Qi, Meng, Lianhong Yin, Lina Xu, et al.. (2016). Dioscin alleviates lipopolysaccharide-induced inflammatory kidney injury via the microRNA let-7i/TLR4/MyD88 signaling pathway. Pharmacological Research. 111. 509–522. 74 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Heqing Huang Breakdown of academic impact, for papers by Guang Liang Breakdown of academic impact, for papers by Lu Lu Breakdown of academic impact, for papers by Nehal M. Elsherbiny Breakdown of academic impact, for papers by Xianglu Rong Breakdown of academic impact, for papers by Hua Zhou Breakdown of academic impact, for papers by Wu Luo Breakdown of academic impact, for papers by Samson Mathews Samuel Breakdown of academic impact, for papers by Haitao Zhang
Rankless by CCL
2026